Connection
Elizabeth Bayliss to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Elizabeth Bayliss has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
Connection Strength |
|
 |
|
 |
|
0.375 |
|
|
|
-
Bayliss EA, Bronsert MR, Reifler LM, Ellis JL, Steiner JF, McQuillen DB, Fairclough DL. Statin prescribing patterns in a cohort of cancer patients with poor prognosis. J Palliat Med. 2013 Apr; 16(4):412-8.
Score: 0.319
-
McGinnis B, Olson KL, Magid D, Bayliss E, Korner EJ, Brand DW, Steiner JF. Factors related to adherence to statin therapy. Ann Pharmacother. 2007 Nov; 41(11):1805-11.
Score: 0.055